BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38178638)

  • 1. Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice.
    Hilton JBW; Kysenius K; Liddell JR; Mercer SW; Hare DJ; Buncic G; Paul B; Wang Y; Murray SS; Kilpatrick TJ; White AR; Donnelly PS; Crouch PJ
    Metallomics; 2024 Jan; 16(1):. PubMed ID: 38178638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
    Steelman AJ; Thompson JP; Li J
    Neurosci Res; 2012 Jan; 72(1):32-42. PubMed ID: 22015947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
    Acs P; Komoly S
    Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.
    Nomura T; Bando Y; You H; Tanaka T; Yoshida S
    Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of oligomeric proanthocyanidin in cuprizone-induced demyelination.
    Wang Q; Wang J; Yang Z; Sui R; Miao Q; Li Y; Yu J; Liu C; Zhang G; Xiao B; Ma C
    Exp Physiol; 2019 Jun; 104(6):876-886. PubMed ID: 30811744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuprizone-mediated demyelination reversibly degrades voiding behavior in mice while sparing brainstem reflex.
    Ramasamy R; Hardy CC; Crocker SJ; Smith PP
    J Neurosci Res; 2022 Sep; 100(9):1707-1720. PubMed ID: 35596557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 24-hydroxycholesterol replacement rate measured in blood is a non-invasive biomarker of brain demyelination and remyelination in cuprizone-treated mice.
    Shankaran M; Mohammed H; Tsang E; Wong PA; Protasio J; Murphy EJ; Bernard F; Chang R; Dellovade T; Turner S; Hellerstein MK
    Exp Neurol; 2023 Jun; 364():114395. PubMed ID: 37003487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
    Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO
    Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Bone Marrow Mesenchymal Stem Cells on Myelin Repair and Emotional Changes of a Cuprizone-Induced Demyelination Model.
    Lei C; Chen H; Chen K
    J Integr Neurosci; 2023 Feb; 22(2):40. PubMed ID: 36992584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.
    Liu L; Belkadi A; Darnall L; Hu T; Drescher C; Cotleur AC; Padovani-Claudio D; He T; Choi K; Lane TE; Miller RH; Ransohoff RM
    Nat Neurosci; 2010 Mar; 13(3):319-26. PubMed ID: 20154684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylcholine 36:1 concentration decreases along with demyelination in the cuprizone animal model and in post-mortem multiple sclerosis brain tissue.
    Trépanier MO; Hildebrand KD; Nyamoya SD; Amor S; Bazinet RP; Kipp M
    J Neurochem; 2018 Jun; 145(6):504-515. PubMed ID: 29574981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of human embryonic stem cell-derived neural precursor cells attenuates cuprizone-induced central nervous system (CNS) demyelination.
    Crocker SJ; Bajpai R; Moore CS; Frausto RF; Brown GD; Pagarigan RR; Whitton JL; Terskikh AV
    Neuropathol Appl Neurobiol; 2011 Oct; 37(6):643-53. PubMed ID: 21276029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis Mediates Cuprizone-Induced Loss of Oligodendrocytes and Demyelination.
    Jhelum P; Santos-Nogueira E; Teo W; Haumont A; Lenoël I; Stys PK; David S
    J Neurosci; 2020 Nov; 40(48):9327-9341. PubMed ID: 33106352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
    Thiessen JD; Zhang Y; Zhang H; Wang L; Buist R; Del Bigio MR; Kong J; Li XM; Martin M
    NMR Biomed; 2013 Nov; 26(11):1562-81. PubMed ID: 23943390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model.
    Tagge I; O'Connor A; Chaudhary P; Pollaro J; Berlow Y; Chalupsky M; Bourdette D; Woltjer R; Johnson M; Rooney W
    PLoS One; 2016; 11(4):e0152480. PubMed ID: 27054832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation strategy to determine reliable demyelination in the cuprizone model.
    Chrzanowski U; Schmitz C; Horn-Bochtler A; Nack A; Kipp M
    Metab Brain Dis; 2019 Apr; 34(2):681-685. PubMed ID: 30607821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences between grey and white matter in cuprizone induced demyelination.
    Gudi V; Moharregh-Khiabani D; Skripuletz T; Koutsoudaki PN; Kotsiari A; Skuljec J; Trebst C; Stangel M
    Brain Res; 2009 Aug; 1283():127-38. PubMed ID: 19524552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination.
    Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y
    Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Effects of Cuprizone on Demyelination in the Corpus Callosum and Hippocampal Progenitors in Young Adult and Aged Mice.
    Hahn KR; Kim W; Jung HY; Kwon HJ; Kim DW; Hwang IK; Yoon YS
    Neurochem Res; 2022 Apr; 47(4):1073-1082. PubMed ID: 35060065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.